DOCSLIB.ORG

Infective Causes of Epilepsy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Infective Causes of Epilepsy 235 Infective Causes of Epilepsy M. Bonello, MBBS, MRCP1 B.D. Michael, MBChB, MRCP, PhD1,2 T. Solomon, MBBS, FRCP, PhD, DTM&H1,2 1 The Walton Centre NHS FoundationTrust, Liverpool, United Kingdom Address for correspondence B.D. Michael, The Institute of Infection 2 The Institute of Infection and Global Health, University of Liverpool, and Global Health, University of Liverpool, 1st Floor Ronald Ross Liverpool, United Kingdom Building, 8 West Derby Street, Liverpool L69 7BE, United Kingdom (e-mail: [email protected]). Semin Neurol 2015;35:235–244. Abstract A wide range of infections of the central nervous system are responsible for both acute seizures and epilepsy. The pathogenesis and clinical semiology of the seizure disorders vary widely between the infective pathogens. The exact mechanisms underlying this are poorly understood, but appear, at least in part, to relate to the pathogen; the degree of cortical involvement; delays in treatment; and the host inflammatory response. The treatment of infective causes of seizures involves both symptomatic treatment with antiepileptic drugs and direct treatment of the underlying condition. In many cases, early treatment of the infection may affect the prognosis of the epilepsy syndrome. The greatest burden of acute and long-term infection-related seizures occurs in resource- Keywords poor settings, where both clinical and research facilities are often lacking to manage ► infection such patients adequately. Nevertheless, education programs may go a long way toward ► encephalitis addressing the stigma, leading to improved diagnosis, management, and ultimately to ► epilepsy better quality of life. Infectious Agents Causing Epilepsy used to make the diagnosis. These include elevated cerebro- spinal fluid (CSF) leukocyte counts, raised protein, evidence of Any infection of the cortex can potentially result in seizures. viral nucleic acid in the CSF by polymerase chain reaction This primarily relies upon the structural damage occurring (PCR), or intrathecal synthesis of antiviral antibody. Neuro- during the infection, although secondary inflammatory pro- imaging can also help (►Fig. 1).1,2 Encephalitis usually cesses may also provoke seizures. Certain conditions, includ- presents with an encephalopathy syndrome for which there ing viral encephalitis and parasitic infections—such as is often a broad differential diagnosis.3 Features raising “cerebral” malaria and neurocysticercosis—are inherently suspicion for infective encephalitis include a history of fever associated with seizures and the risk of developing epilepsy. or coryzal illness, recent travel, and inadequate vaccination.1 Other conditions, such as bacterial meningitis, can cause A wide range of pathogens can cause encephalitis. Antibody- seizures in the acute setting, although this is less frequent associated encephalitis, which may be paraneoplastic or de and they rarely result in long-term epilepsy. Here we will novo, is of increasingly recognized importance, but it is review the most common central nervous system (CNS) beyond the scope of this article and is covered elsewhere in infectious disorders causing epilepsy, specifically focusing this themed edition. This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. on viral encephalitis and parasitic infections. Encephalitis results in roughly 19,000 hospitalizations and 1,400 deaths per year in the United States4 with a reported Viral Encephalitis incidence between 0.7 to 13.8 per 100,000 per year.1,3,5 It is Encephalitis encompasses a broad range of pathophysiologi- an important condition as delays in diagnosis and in starting cal process that result in inflammation of brain parenchyma treatment can result in significant morbidity and mortality. and therefore the diagnosis is fundamentally a histopatho- Acute symptomatic seizures occur in 2 to 67% of patients with logical one.1,2 In view of the impracticality of obtaining brain a diagnosis of encephalitis overall.4 The incidence of acute tissue, surrogate markers of brain inflammation are routinely symptomatic seizures and the subsequent development of Issue Theme Etiology of Epilepsy; Guest Copyright © 2015 by Thieme Medical DOI http://dx.doi.org/ Editors: Philip Smith, MD, FRCP, Publishers, Inc., 333 Seventh Avenue, 10.1055/s-0035-1552619. FAcadMEd, and Rhys Thomas, BSc, MRCP, New York, NY 10001, USA. ISSN 0271-8235. MSc, PhD Tel: +1(212) 584-4662. 236 Infective Causes of Epilepsy Bonello et al. zoster virus and enteroviruses. Epidemic encephalitis most commonly occurs in geographically restricted seasonal epi- demics and is caused by arthropod-borne viruses (arbovi- ruses), although clinicians need to be vigilant to the potential for advances in the geographical distribution of these patho- gens. Globally, the most important epidemic cause is Japanese encephalitis virus, while others include West Nile virus, tick- borne encephalitis virus and Nipah virus (►Table 1).5 Herpes Simplex Virus Encephalitis Herpes simplex virus (HSV) encephalitis has an annual inci- dence of 1 in 250,000 to 500,000, although this may be an underestimate.8 Herpes simplex virus type 1 is an α herpes double-stranded DNA virus with which most people are infected by adulthood.8 It is transmitted by droplet spread and crosses the mucous membranes of the naso-oral cavity and then travels by retrograde axonal transport to sensory ganglia, predominantly the trigeminal ganglion. There it Fig. 1 Magnetic resonance image of brain (coronal T2-weighted) achieves latency, but reactivates periodically, traveling by showing typical temporal lobe changes in confirmed herpes simplex anterograde axonal transport to the cutaneous nerve end- virus type 1 (HSV1) encephalitis. ings, resulting in spread of the virus, in some cases associated with a localized vesicular eruption, “herpes labialis.” Triggers for viral reactivation include stress, local trauma, fever, epilepsy vary with the cause of encephalitis, the patient’s immunosuppression, menstruation, or hormone imbalance. comorbidities, delays in starting treatment, and the degree of The mechanisms resulting in latency and reactivation are not cortical inflammation.6 Epidemiological studies of seizures fully understood, but toll-like receptors and the type 1 and 2 and the long-term outcome for encephalitis are limited and interferon response probably play a crucial role in initially available data are mainly from passive surveillance; therefore, establishing and subsequently maintaining latency.9 Rarely, they are prone to underestimate, particularly in resource- the virus replicates in the brain, causing encephalitis although poor settings. it is unclear whether this result from further retrograde Patients with encephalitis risk developing seizures in the axonal transport after reactivation in the trigeminal ganglion, acute setting, but are also more likely to develop later or whether this is due to reactivation of HSV already latent unprovoked seizures as described by the International League within the brain (►Fig. 2). Against Epilepsy (ILAE).7 Overall, patients with encephalitis Herpes simplex virus type 1 encephalitis has a bimodal age are around 16 times more likely than the general population distribution, with one-third of cases occurring in young to develop epilepsy.4 Of those who have seizures during the adults and one-half of cases occurring in people older than acute encephalitic illness, the risk is higher at a 22 times more 50 years.10 Seizures occur in approximately 40% of people likely. Even those who do not suffer from acute symptomatic with HSV 1 encephalitis during the acute illness and may be seizures during the acute viral encephalitis are 10 times more the presenting symptom.11 The seizures are typically focal, likely to develop later unprovoked seizures. The annual with and without cognitive involvement, reflecting temporal incidence of epilepsy due to encephalitis in the United States lobe and to a lesser extent frontal lobe infection. Clinical is approximately the same as that due to head injuries, even features that typically precede seizures include alterations in though there are 1.4 million cases of CNS trauma per year, cognition, consciousness, personality, or behavior, in the compared with fewer than 50,000 cases of CNS infection.4 context of an intercurrent or recent febrile illness.3 However, This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. Most commonly, seizures develop within the first 5 years approximately 11% of patients with HSV encephalitis are of the acute encephalitic illness, but they may occur up to afebrile on admission.12 Associated clinical features include 20 years after the acute event. The pathogen may be impor- headache, nausea, vomiting, and features suggesting menin- tant in determining whether a person subsequently develops gism and raised intracranial pressure.12 The presence of acute epilepsy in the long term. For example, encephalitis caused by symptomatic seizures was associated with a worse outcome La Crosse virus has a cumulative incidence of epilepsy of 10 to in a series of patients with HSV encephalitis; furthermore, the 12% while Nipah virus encephalitis has an incidence of development of status epilepticus is associated with a worse approximately 2.2%.4 outcome in encephalitis more broadly.4,13 In addition, a greater impairment in consciousness, older age, and a delay Causes of Infectious Encephalitis in starting acyclovir treatment of > 48 hours
Load more

Recommended publications
  • Seizures in Encephalitis
    Neurology Asia 2008; 13 : 1 – 13 REVIEW ARTICLES Seizures in encephalitis Usha Kant Misra DM, *C T Tan MD, Jayantee Kalita DM Department of Neurology, Sanjay Gandhi PGIMS, Lucknow, India; *Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia Abstract A large number of viruses can result in encephalitis. However, certain viruses are more prevalent in certain geographical regions. For example, Japanese encephalitis (JE) and dengue in South East Asia and West Nile in Middle East whereas Herpes simplex encephalitis (HSE) occurs all over the world without any seasonal or regional variation. Encephalitis can result in acute symptomatic seizures and remote symptomatic epilepsy. Risk of seizures after 20 years is 22% following encephalitis and 3% after meningitis with early seizures. Amongst the viruses, HSE is associated with most frequent and severe epilepsy. Seizures may be presenting feature in 50% because of involvement of highly epileptogenic frontotemporal cortex. Presence of seizures in HSE is associated with poor prognosis. HSE can also result in chronic and relapsing form of encephalitis and may be an aetiology factor in drug resistant epilepsy. Amongst the Flaviviruses, Japanese encephalitis is the most common and is associated with seizures especially in children. The frequency of seizures in JE is reported to be 6.9% to 46%. Associated neurocysticercosis in JE patients may aggravate the frequency and severity of seizures. Other flaviviruses such as equine, St Louis, and West Nile encephalitis can also produce seizures. In Nipah encephalitis, seizures are commoner in relapsed and late-onset encephalitis as compared to acute encephalitis (50% vs 24%). Other viruses like measles, varicella, mumps, influenza and enteroviruses may result in encephalitis and seizures.
    [Show full text]
  • Progressive Multifocal Leukoencephalopathy and the Spectrum of JC Virus-​Related Disease
    REVIEWS Progressive multifocal leukoencephalopathy and the spectrum of JC virus- related disease Irene Cortese 1 ✉ , Daniel S. Reich 2 and Avindra Nath3 Abstract | Progressive multifocal leukoencephalopathy (PML) is a devastating CNS infection caused by JC virus (JCV), a polyomavirus that commonly establishes persistent, asymptomatic infection in the general population. Emerging evidence that PML can be ameliorated with novel immunotherapeutic approaches calls for reassessment of PML pathophysiology and clinical course. PML results from JCV reactivation in the setting of impaired cellular immunity, and no antiviral therapies are available, so survival depends on reversal of the underlying immunosuppression. Antiretroviral therapies greatly reduce the risk of HIV-related PML, but many modern treatments for cancers, organ transplantation and chronic inflammatory disease cause immunosuppression that can be difficult to reverse. These treatments — most notably natalizumab for multiple sclerosis — have led to a surge of iatrogenic PML. The spectrum of presentations of JCV- related disease has evolved over time and may challenge current diagnostic criteria. Immunotherapeutic interventions, such as use of checkpoint inhibitors and adoptive T cell transfer, have shown promise but caution is needed in the management of immune reconstitution inflammatory syndrome, an exuberant immune response that can contribute to morbidity and death. Many people who survive PML are left with neurological sequelae and some with persistent, low-level viral replication in the CNS. As the number of people who survive PML increases, this lack of viral clearance could create challenges in the subsequent management of some underlying diseases. Progressive multifocal leukoencephalopathy (PML) is for multiple sclerosis. Taken together, HIV, lymphopro- a rare, debilitating and often fatal disease of the CNS liferative disease and multiple sclerosis account for the caused by JC virus (JCV).
    [Show full text]
  • Encephalitis Fact Sheet
    Encephalitis Fact Sheet What is encephalitis? Encephalitis is an inflammation (irritation and swelling) of the brain tissue. It can occur as a primary illness or as a result of another illness elsewhere in the body. Frequently caused by an infection with a virus, encephalitis can be mild or severe, but severe cases are rare. Who gets encephalitis? Anyone can get encephalitis, but young children, older adults, and persons with weakened immune systems are more at risk. How is encephalitis spread? Primary encephalitis occurs when a virus directly infects the brain. Viruses that are carried by infected mosquitoes and ticks can cause primary encephalitis. Other viruses can cause an illness and then encephalitis can develop as a complication of the viral illness. When encephalitis develops after another infection, it is called post-infectious encephalitis. Post-infectious encephalitis most commonly follows a bout of chickenpox, mumps, or measles. What are the symptoms of encephalitis? Encephalitis frequently causes headache, fever, confused thinking, seizures, or problems with vision, speech, or movement. Infants and young children might have nausea, vomiting, body stiffness, constant crying, and poor feeding. How soon after exposure do symptoms appear? Encephalitis can occur within two to three weeks after a viral illness. Symptoms begin within a few days to one or two weeks after the bite from an infected mosquito. How is encephalitis diagnosed? Medical evaluation and special tests are needed to confirm the diagnosis. Anyone with a severe headache, fever, and altered mental status should seek medical care immediately. What is the treatment for encephalitis? Doctors might prescribe antiviral drugs, anti-inflammatory drugs, or other treatments for the symptoms as needed.
    [Show full text]
  • Meningitis/Encephalitis Pathogen Panel
    Meningitis/Encephalitis Pathogen Panel The list of pathogens which can potentially cause meningitis, encephalitis, and meningoencephalitis is broad. Early effective therapy for both bacterial and certain viral pathogens has been associated with improved outcomes. Patients whose history, exam, and/or imaging suggests one of these conditions should have a lumber puncture performed with appropriate diagnostic testing including a cell count with differential, protein, and glucose. Additional tests to consider include bacterial culture, cryptococcal antigen testing, fungal cultures, cultures for acid fast bacilli and/or the new Meningitis/Encephalitis Pathogen Panel. Nebraska Medicine has recently introduced a new FDA-approved test called the Meningitis/Encephalitis Pathogen Panel (MEPP). This test uses a nested multiplex PCR-approach to amplify DNA targets directly from cerebrospinal fluid (CSF) in patients with signs and symptoms of meningitis or encephalitis. It is able to detect a variety of common bacterial, viral, and fungal pathogens (Table 1). Table 1: Pathogens Detected by Meningitis/Encephalitis Pathogen Panel Bacteria Viruses Yeast Gram-negative Cytomegalovirus Cryptococcus Escherichia coli K1 Enterovirus neoformans/gattii Haemophilus influenzae Herpes simplex virus 1 Neisseria meningitidis Herpes simplex virus 2 Gram-positive Human herpesvirus 6 Listeria monocytogenes Human parechovirus Streptococcus agalactiae (Group B Strep) Varicella zoster virus (VZV) Streptococcus pneumoniae This test is sensitive and very specific (see Supplementary Table 1 for complete detail), and should only be performed in patients where CNS infection is being seriously considered. Previous studies have shown that using clinical and CSF criteria to determine when to perform PCR testing is unlikely to miss clinically significant results and is highly cost-effective.1-3 For example Wilen, et al.3 restricted herpes virus and enterovirus PCR testing to patients who were: age <2 years, immunosuppressed, or who had >10 WBCs/µl.
    [Show full text]
  • The Approach to Patients with ''Non-Epileptic Seizures''
    498 Postgrad Med J: first published as 10.1136/pgmj.2004.029785 on 5 August 2005. Downloaded from REVIEW The approach to patients with ‘‘non-epileptic seizures’’ J D C Mellers ............................................................................................................................... Postgrad Med J 2005;81:498–504. doi: 10.1136/pgmj.2004.029785 Up to one fifth of patients who present to specialist clinics with loose shorthand to refer to the psychological attacks alone.12 The terms psychogenic NES and seizures do not have epilepsy. The majority of such patients functional seizures overcome some of these suffer from psychologically mediated episodes; dissociative objections but formal psychiatric classification seizures, often referred to as ‘‘non-epileptic seizures’’. This systems provide clearly defined labels. Unfor- tunately, though, there are still inconsistencies: paper describes the diagnostic evaluation of seizure thus, within DSM IV13 such attacks are classified disorders, including clinical assessment and the role of special under somatoform disorder and in ICD 1014 the investigations. The organic and psychiatric imitators of diagnostic label ‘‘dissociative convulsions’’, is classified within the group of conversion dis- epilepsy are outlined and findings on psychiatric assessment orders. It is the latter terminology that will be are reviewed. This group of patients often proves difficult to adopted here. engage in appropriate treatment and an approach to As we have seen, dissociative convulsions or seizures (DS) are common, the diagnosis is often explaining the diagnosis is described. As yet there are no missed, and when it is patients not only fail to controlled trials of treatment in this disorder but preliminary receive appropriate treatment but are subject to evidence suggests cognitive behavioural therapy is both a unnecessary, costly,15 and potentially harmful medical interventions.
    [Show full text]
  • Granulomatous Meningoencephalitis and Necrotizing Encephalitis
    Granulomatous Meningoencephalitis and Necrotizing Encephalitis A. Courtenay Freeman, DVM Marc Kent, DVM, DACVIM (Small Animal and Neurology) Scott J. Schatzberg, DVM, PhD, DACVIM (Neurology) BASIC INFORMATION TREATMENT AND FOLLOW-UP Description Granulomatous meningoencephalitis (GME) and necrotizing Treatment Options encephalitis (NE) are disorders that arise from inflammation of the Because GME and NE are caused by inflammation, treatment is brain and/or spinal cord and their coverings (the meninges). These initially directed at suppressing the inflammation with steroids. diseases affect predominantly young, small-breed dogs. High doses are used initially; as the animal improves, the dosage Causes may be lowered gradually over the course of months. The goal Both GME and NE are presently considered to be autoimmune dis- of therapy is to reduce the dosage to the minimal amount needed orders, meaning that the body launches an abnormal attack against to control the clinical signs. Side effects of steroids include its own nervous system tissues. Potential triggers for the autoim- increased thirst, appetite, and urination. Animals may breathe mune attack may include infections and vaccinations. Genetics heavily and pant excessively. Long-term side effects include a may also play a role in the development of GME and NE. thin hair coat, poor wound healing, and muscle loss. Steroid ther- Although any breed of dog may be affected with GME, toy apy can also make the dog prone to infections of the skin and breeds are affected most often. Breeds commonly affected by NE urinary tract. Notify your veterinarian if any of these side effects include the pug, Maltese, Yorkshire terrier, Chihuahua, French occur.
    [Show full text]
  • Signs of Teen Drug Abuse 14 EDITS
    Signs of Teen Drug Abuse SoberCollege.com Teen Drug Abuse Are you concerned that your child is using drugs or alcohol? Whether you are concerned about changes in appearance or behavior Sober College can help you find out more about a range of symptoms associated with drug use. Table of Contents: Symptoms Drug Types ......................................................................................................................................................... 2 Red eyes ...................................................................................................................................................... 3 Weight loss ...................................................................................................................................................... 4 Cuts, sores or bruises...................................................................................................................................... 5 Deterioration of physical appearance .......................................................................................................... 6 Shakes and tremors ........................................................................................................................................ 7 Anger issues ..................................................................................................................................................... 8 Financial difficulties ......................................................................................................................................
    [Show full text]
  • An Overview of Psychogenic Non-Epileptic Seizures: Etiology, Diagnosis and Management
    REVIEW ARTICLE COPYRIGHT © 2018 THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES INC. An Overview of Psychogenic Non-Epileptic Seizures: Etiology, Diagnosis and Management Ángela Milán-Tomás, Michelle Persyko, Martin del Campo, Colin M. Shapiro, Karl Farcnik ABSTRACT: The purpose of this review is to provide an update of the research regarding the etiology, diagnosis and management of psychogenic non-epileptic seizures (PNES). A literature search using Pubmed, Ovid MEDLINE and EMBASE database was performed from 2000 up to August 2017. We have evaluated the different factors leading to PNES as well as the diagnostic approach and management of this disorder which continue to be very difficult. The coexistence of epilepsy and PNES poses special challenges and requires the coordinated efforts of the family physicians, psychiatrists, psychologists and neurologists. Although this condition has an overall poor prognosis, a multidisciplinary approach in the diagnosis and management of this disorder would likely improve the outcomes. We have proposed a diagnostic and treatment algorithm for PNES and suggested a national registry of patients suffering from this condition. The registry would contain data regarding treatment and outcomes to aid in the understanding of this entity. RÉSUMÉ: Vue d’ensemble des crises psychogènes non-épileptiques: étiologie, diagnostic et prise en charge. L’objectif de cet article est de présenter une mise à jour des activités de recherche qui concernent l’étiologie, le diagnostic et la prise en charge des crises psychogènes non-épileptiques (CPNE). Pour ce faire, nous avons mené de 2000 à août 2017 une recherche bibliographique au moyen des bases de données suivantes : PubMed, Ovid MEDLINE et Embase.
    [Show full text]
  • Part Ii – Neurological Disorders
    Part ii – Neurological Disorders CHAPTER 4 EPILEPSY Dr William P. Howlett 2012 Kilimanjaro Christian Medical Centre, Moshi, Kilimanjaro, Tanzania BRIC 2012 University of Bergen PO Box 7800 NO-5020 Bergen Norway NEUROLOGY IN AFRICA William Howlett Illustrations: Ellinor Moldeklev Hoff, Department of Photos and Drawings, UiB Cover: Tor Vegard Tobiassen Layout: Christian Bakke, Division of Communication, University of Bergen E JØM RKE IL T M 2 Printed by Bodoni, Bergen, Norway 4 9 1 9 6 Trykksak Copyright © 2012 William Howlett NEUROLOGY IN AFRICA is freely available to download at Bergen Open Research Archive (https://bora.uib.no) www.uib.no/cih/en/resources/neurology-in-africa ISBN 978-82-7453-085-0 Notice/Disclaimer This publication is intended to give accurate information with regard to the subject matter covered. However medical knowledge is constantly changing and information may alter. It is the responsibility of the practitioner to determine the best treatment for the patient and readers are therefore obliged to check and verify information contained within the book. This recommendation is most important with regard to drugs used, their dose, route and duration of administration, indications and contraindications and side effects. The author and the publisher waive any and all liability for damages, injury or death to persons or property incurred, directly or indirectly by this publication. CONTENTS EPILEPSY 79 EPILEPSY SYNDROMES � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 79 CLASSIFICATION�
    [Show full text]
  • Review of Case Definitions for Myalgic Encephalomyelitis/Chronic Fatigue
    Lim and Son J Transl Med (2020) 18:289 https://doi.org/10.1186/s12967-020-02455-0 Journal of Translational Medicine REVIEW Open Access Review of case defnitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Eun‑Jin Lim and Chang‑Gue Son* Abstract Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease with unknown causes. From the perspectives on the etiology and pathophysiology, ME/CFS has been labeled diferently, which infu‑ enced changes in case defnitions and terminologies. This review sought to feature aspects of the history, develop‑ ments, and diferential symptoms in the case defnitions. Methods: A search was conducted through PubMed published to February 2020 using the following search key‑ words: case defnition AND chronic fatigue syndrome [MeSH Terms]. All reference lists of the included studies were checked. Of the included studies, the number of citations and the visibility in the literatures of the defnitions were considered for comparisons of the criteria. Results: Since the frst ’ME’ case defnition was developed in 1986, 25 case defnitions/diagnostic criteria were cre‑ ated based on three conceptual factors (etiology, pathophysiology, and exclusionary disorders). These factors can be categorized into four categories (ME, ME/CFS, CFS, and SEID) and broadly characterized according to primary disorder (ME‑viral, CFS‑unknown, ME/CFS‑infammatory, SEID‑multisystemic), compulsory symptoms (ME and ME/ CFS‑neuroinfammatory, CFS and SEID‑fatigue and/or malaise), and required conditions (ME‑infective agent, ME/ CFS, CFS, SEID‑symptoms associated with fatigue, e.g., duration of illness). ME and ME/CFS widely cover all symptom categories, while CFS mainly covers neurologic and neurocognitive symptoms.
    [Show full text]
  • Tick-Borne Encephalitis (TBE)
    Tick-borne Encephalitis (TBE) Tick-borne encephalitis, or TBE, is a human viral infectious disease involving the central nervous system. TBE is caused by the tick- borne encephalitis virus (TBEV), a member of the family Flaviviridae, and was initially isolated in 1937. Three virus sub-types are described: European or Western tick-borne encephalitis virus, Siberian tick-borne encephalitis virus, and Far eastern Tick-borne encephalitis virus (formerly known as Russian Spring Summer encephalitis virus, RSSEV). The family Flaviviridae includes several tick-borne viruses affecting humans. These viruses are closely related to TBEV and Far- eastern TBE, and include Omsk hemorrhagic fever virus in Siberia, Kyasanur Forest disease virus in India and its close relative, Alkhurma virus in Saudi Arabia. Louping ill virus (United Kingdom) is also a member of this family; it causes disease primarily in sheep and has been reported as the cause of a TBE-like illness in laboratory workers and persons with contact to sick sheep (e.g., veterinarians, butchers). In the USA and Russia, another tick-borne flavivirus, Powassan virus, is responsible of encephalitis in human. Transmission Ticks, specifically hard ticks of the family Ixodidae, act as both the vector and reservoir for TBEV. The main hosts are small rodents, with humans being accidental hosts. Large animals serve as feeding hosts for the ticks, but do not play a role in maintenance of the virus. The virus can chronically infect ticks and is transmitted both transtadially (from larva to nymph to adult ticks) and transovarially (from adult female tick to eggs). TBE cases occur in humans most frequently in rural areas and during the highest period of tick activity (between April and November).
    [Show full text]
  • First Responders
    (067UDLQLQJ (SLOHSV\DQG 6HL]XUH0DQDJHPHQW 3$57,&,3$17·6*8,'( 7KH(SLOHSV\)RXQGDWLRQOHDGVWKHÀJKWWRVWRSVHL]XUHVÀQGDFXUHDQGRYHUFRPHWKHFKDOOHQJHV created by epilepsy. 7KH(SLOHSV\)RXQGDWLRQLVWKHQDWLRQDOYROXQWDU\DJHQF\VROHO\GHGLFDWHGWRWKHZHOIDUHRIWKHQHDUO\ PLOOLRQSHRSOHZLWKHSLOHSV\LQWKH86DQGWKHLUIDPLOLHV7KHRUJDQL]DWLRQZRUNVWRHQVXUHWKDW SHRSOHZLWKVHL]XUHVDUHDEOHWRSDUWLFLSDWHLQDOOOLIHH[SHULHQFHVWRLPSURYHKRZSHRSOHZLWKHSLOHSV\ DUHSHUFHLYHGDFFHSWHGDQGYDOXHGLQVRFLHW\DQGWRSURPRWHUHVHDUFKIRUDFXUH,QDGGLWLRQWR SURJUDPVFRQGXFWHGDWWKHQDWLRQDOOHYHOHSLOHSV\FOLHQWVWKURXJKRXWWKH8QLWHG6WDWHVDUHVHUYHGE\ (SLOHSV\)RXQGDWLRQDIÀOLDWHVDURXQGWKHFRXQWU\ )RUPRUHLQIRUPDWLRQYLVLWWKH(SLOHSV\)RXQGDWLRQZHEVLWHZZZHSLOHSV\IRXQGDWLRQRUJ or call 800-332-1000. Table of Contents Introduction .....................................................................................................................1 About this Training .........................................................................................................1 What is a Seizure? ..........................................................................................................2 Typical Causes for Seizures ............................................................................3 What is Epilepsy? ...........................................................................................................4 Causes of Epilepsy ..........................................................................................4 Danger of Prolonged Seizure ..........................................................................5
    [Show full text]